163 filings
Page 5 of 9
8-K
a6moebb ut5bih2
5 Aug 21
NGM Bio Provides Business Highlights and Reports Second Quarter 2021 Financial Results
4:17pm
8-K
n9rdb5vq6ln9vkuk
1 Jul 21
Entry into a Material Definitive Agreement
7:26am
8-K
gypghf
10 Jun 21
Submission of Matters to a Vote of Security Holders
5:27pm
8-K
vprhdu 8f
24 May 21
NGM Bio Reports Topline Results from 24-Week Phase 2b ALPINE 2/3 Study of Aldafermin in NASH
7:09am
8-K
3m7t us9o48
6 May 21
NGM Bio Provides Business Highlights and Reports First Quarter 2021 Financial Results
4:16pm
DEFA14A
3cvq84elhl9 z5sp
28 Apr 21
Additional proxy soliciting materials
4:38pm
8-K
8cb9rjc
28 Apr 21
NGM Announces Nomination of Roger M. Perlmutter for Election to its Board of Directors
4:26pm
DEFA14A
d7xkkvhffq9c6 2e0
28 Apr 21
Additional proxy soliciting materials
4:24pm
S-8
ei2nin3r ulu7c2o
15 Mar 21
Registration of securities for employees
4:53pm
8-K
40a rlj5irve0
15 Mar 21
Entry into a Material Definitive Agreement
4:50pm
8-K
9v78 8vc0ughw8
4 Mar 21
NGM Bio Provides Business Highlights and Reports Fourth Quarter and Full Year 2020 Financial Results
4:14pm
8-K
411zs8a
6 Jan 21
Results of Operations and Financial Condition
4:24pm
424B5
hkvrn
6 Jan 21
Prospectus supplement for primary offering
4:23pm
424B5
qx77p 3bnv
4 Jan 21
Prospectus supplement for primary offering
4:10pm
8-K
129t8u yt2
12 Nov 20
NGM Bio Provides Business Highlights and Reports Third Quarter 2020 Financial Results
4:32pm